AI assistant
Sending…
Immuneering Corp — Director's Dealing 2026
Jan 15, 2026
32973_dirs_2026-01-15_1d11e327-c9a7-4f96-9a0c-bc2fe872f29c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2026-01-13
Reporting Person: Neufeld Leah R (CHIEF PEOPLE OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-01-13 | Class A Common Stock | P | 2626 | $4.153 | Acquired | 25970 | Direct |
More from Immuneering Corp
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Major Shareholding Notification
2026
Jan 22